Six-month results of intravitreal aflibercept injections for patients with polypoidal choroidal vasculopathy
Authors:
- 23 February 2015
- journal article
- Published by BMJ in British Journal of Ophthalmology
- Vol. 99 (8) , 1087-1091
Abstract
Background This study aims to evaluate the therapeutic effect of intravitreal aflibercept injection for polypoidal choroidal vasculopathy (PCV). Methods Eighteen eyes of 17 consecutive patients with PCV received three consecutive monthly intravitreal injections of aflibercept and one additional injection 2 months later (four injections totally). All patients underwent eye examinations, which included best-corrected visual acuity (BCVA), fluorescein angiography, indocyanine green angiography, and optical coherence tomography. The primary endpoint of the study was the regression of polypoidal lesions. The secondary endpoints were BCVA, central retinal thickness (CRT) and changes in retinal exudation. Results Six months after the first aflibercept injection, the polypoidal lesions were completely resolved in 14 eyes (77.7%) and partially resolved in 4 eyes (22.2%). Although branching choroidal vascular networks were still present in all eyes, retinal exudative changes had completely resolved in 17 eyes (94.4%), and the mean CRT decreased significantly from 407.2±100.1 µm to 229.1±57.2 µm (pConclusions At 6 months, aflibercept monotherapy effectively reduced polyps, retinal exudation and CRT in patients with PCV.Keywords
This publication has 25 references indexed in Scilit:
- Comparison of the Effect of Ranibizumab and Verteporfin for Polypoidal Choroidal Vasculopathy: 12-Month LAPTOP Study ResultsAmerican Journal of Ophthalmology, 2013
- POLYPOIDAL CHOROIDAL VASCULOPATHYRetina, 2013
- EVEREST STUDYRetina, 2012
- Intravitreal bevacizumab and ranibizumab injections for patients with polypoidal choroidal vasculopathyEye, 2011
- Intravitreal bevacizumab (Avastin) with or without photodynamic therapy for the treatment of polypoidal choroidal vasculopathyBritish Journal of Ophthalmology, 2008
- Efficacy of intravitreal bevacizumab for polypoidal choroidal vasculopathyBritish Journal of Ophthalmology, 2007
- Polypoidal choroidal vasculopathy: natural historyAmerican Journal of Ophthalmology, 2002
- Idiopathic Polypoidal Choroidal Vasculopathy in Japanese PatientsArchives of Ophthalmology (1950), 1999
- The Expanding Clinical Spectrum of Idiopathic Polypoidal Choroidal VasculopathyArchives of Ophthalmology (1950), 1997
- INDOCYANINE GREEN VIDEOANGIOGRAPHY OF IDIOPATHIC POLYPOIDAL CHOROIDAL VASCULOPATHYRetina, 1995